CPT® Code 87594

Pneumocystis jirovecii is a type of fungus that is primarily responsible for causing pneumocystis pneumonia, a serious infection that predominantly affects individuals who are immunocompromised, such as those with HIV/AIDS, cancer patients undergoing chemotherapy, or organ transplant recipients. The detection of this infectious agent is critical for timely diagnosis and treatment. The CPT® Code 87594 refers to the method of infectious agent detection by nucleic acid, specifically targeting the DNA or RNA of Pneumocystis jirovecii. The amplified probe technique, which includes the use of real-time polymerase chain reaction (RT-PCR), is recognized as the gold standard for identifying this pathogen. This technique is highly sensitive and specific, allowing for the accurate detection of the organism in clinical specimens. Typically, specimens for testing may include bronchoalveolar lavage or bronchial washings, which are preferred when available, although sputum or cough expectorate samples can also be utilized. The process begins with the extraction of nucleic acid from the collected sample, which is then incorporated into a PCR mixture. The PCR platform amplifies a designated region of the extracted DNA, and a melting curve analysis is performed to ascertain the presence of Pneumocystis jirovecii. During this analysis, the sample is subjected to heating in the presence of a dye, which allows for the differentiation of mutated DNA from normal DNA strands based on their melting points, ultimately leading to a positive or negative test result.